Jubilant Pharmova Limited

NSE BSE

Performance

Today's Low		Today's High
1,137.10 1,138.95		1,154.00 1149.30

52 Week Low		52 Week High
452.80 (13-Dec-2023) 453.60 (13-Dec-2023)		1,309.90 (07-Nov-2024) 1,309.00 (07-Nov-2024)

Open: 1,149.40 1,149.00

Previous Close: 1,149.40 1,149.00

Volume: 0.04

Total Traded value: 0.45 (₹ Lakhs)

Upper circuit: 1,379.25 687.10

Lower circuit: 919.55 458.10

Market Depth

Buy Order Quantity		Sell Order Quantity
10,527		31,648

Bid Price	Quantity
1,139.35	4.00
1,139.20	4.00
1,139.10	15.00
1,138.80	26.00
1,138.65	5.00
Total:	10,527

Ask Price	Quantity
1,139.90	10.00
1,140.20	1.00
1,140.25	10.00
1,140.30	16.00
1,140.35	1.00
Total:	31,648

Fundamentals

Market Cap:	₹181.51 Cr
PE Ratio (TTM):	602.02
PB Ratio:	7.96
Industry P/E:	26.30
Debt to Equity:	-

ROE:	1.32
EPS (TTM):	1.91
Book Value:	138.42
Face Value:	1.00

Financials

	Sep, 2023	Jun, 2023	Mar, 2023	Dec, 2022	Sep, 2022
Revenue	186.30 Cr	217.40 Cr	199.84 Cr	182.74 Cr	222.97 Cr
Profit	-0.40 Cr	1.90 Cr	-30.86 Cr	-5.89 Cr	91.81 Cr
Expense	204.50 Cr	231.00 Cr	214.73 Cr	201.75 Cr	230.89 Cr
Comprehensive income	-0.60 Cr	1.70 Cr	-30.13 Cr	-5.69 Cr	92.01 Cr
EPS	-0.03	0.12	-1.94	-0.37	5.77

Jubilant Pharmova Limited is a global pharmaceutical company that operates in an integrated manner. The company is divided into three segments: Pharmaceuticals, Contract Research & Development Services, and Proprietary Novel Drugs.

In the Pharmaceuticals segment, Jubilant Pharmova engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations. Additionally, the company sells radiopharmaceuticals through a network of 48 radio pharmacies in the United States.

The Contract Research & Development Services segment of Jubilant Pharmova provides collaborative research services to pharmaceutical innovators. This segment focuses on supporting and assisting in the development of new drugs and therapies.

Lastly, the Proprietary Novel Drugs segment of Jubilant Pharmova is dedicated to developing therapies in the areas of oncology and auto-immune disorders. This segment aims to bring innovative and effective treatments to patients suffering from these conditions.

Jubilant Pharmova Limited was previously known as Jubilant Life Sciences Limited and underwent a name change in February 2021. The company was established in 1978 and has its headquarters in Noida, India.

Company name	Listing date	Industry	NSE symbol BSE symbol
Jubilant Pharmova Limited	Jun, 2003 Jun, 1981	Pharmaceuticals Pharmaceuticals	JUBLPHARMA JUBLPHARMA

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

Promoters

50.68%
Public

48.74%
Shares held by Employee Trusts

0.59%
Promoters

50.68%
Public

48.74%
Shares held by Employee Trusts

0.59%
Promoters

50.68%
Public

49.19%
Shares held by Employee Trusts

0.13%
Promoters

50.68%
Public

49.19%
Shares held by Employee Trusts

0.13%
Promoters

50.68%
Public

49.26%
Shares held by Employee Trusts

0.07%

Promoters
	50.68%

Public
	48.74%

Shares held by Employee Trusts
	0.59%

Promoters
	50.68%

Public
	48.74%

Shares held by Employee Trusts
	0.59%

Promoters
	50.68%

Public
	49.19%

Shares held by Employee Trusts
	0.13%

Promoters
	50.68%

Public
	49.19%

Shares held by Employee Trusts
	0.13%

Promoters
	50.68%

Public
	49.26%

Shares held by Employee Trusts
	0.07%

Jubilant Pharmova Limited FAQ's

What is the range of today's stock performance for Jubilant Pharmova Limited?

Today's stock performance witnessed a fluctuation from a minimum of 1,137.10 on the NSE (National Stock Exchange) to a maximum of 1,154.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,138.95 to a high of 1,149.30.

What are the 52-week low and high values for Jubilant Pharmova Limited?

The stock's performance over the past 52 weeks reveals a low of 452.80 (occurred on 13-Dec-2023) and a high of 1,309.90 (achieved on 07-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 453.60 (on 13-Dec-2023), and the 52-week high is 1,309.00 (on 07-Nov-2024).

What was the opening and previous closing prices for Jubilant Pharmova Limited?

The stock's performance over the past 52 weeks reveals a low of 452.80 (occurred on 13-Dec-2023) and a high of 1,309.90 (achieved on 07-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 453.60 (on 13-Dec-2023), and the 52-week high is 1,309.00 (on 07-Nov-2024).

What is the total volume and traded value for Jubilant Pharmova Limited for the day?

The total volume is 0, and the total traded value is 0.45 (₹ Lakhs).

What are the upper and lower circuit limits for Jubilant Pharmova Limited?

The upper circuit limit is 1,379.25, and the lower circuit limit is 919.55.

What is the market cap and PE ratio for Jubilant Pharmova Limited?

The market cap is ₹181.51 Cr, and the PE ratio (TTM) is 31.98.

What is the PB ratio, industry P/E, and debt to equity ratio for Jubilant Pharmova Limited?

The PB ratio is 8.23, industry P/E is 26.30 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Jubilant Pharmova Limited?

ROE is 1.32, EPS is 1.91, book value is 138.42

What are the revenue and profit figures for the latest quarter and previous quarters for Jubilant Pharmova Limited?

In Sep 2023, Revenue is ₹1863000000.00, and Profit is ₹-4000000.00. In Jun 2023, Revenue is ₹2174000000.00, and Profit is ₹19000000.00.

When was Jubilant Pharmova Limited listed, and what industry does it belong to?

The company, Jubilant Pharmova Limited, was listed in Jun 2003 and belongs to the Pharmaceuticals industry. Its NSE symbol is JUBLPHARMA.

What is the current shareholding pattern of the Jubilant Pharmova Limited?

As of latest available update, promoters hold 50.68%, the public holds 48.74%, and Employee Trusts holds 0.59.

Search

Navigation section